Form DEF 14A Stardust POWER INC. for: 21 April
Form DEF 14A Stardust POWER INC. for: 21 April Form DEF 14A Stardust POWER INC. for: 21 April Source: Investing.com News
Category macro
Northern Trust Declares $0.80 Quarterly Dividend
Northern Trust Declares $0.80 Quarterly Dividend Northern Trust Declares $0.80 Quarterly Dividend Source: Investing.com News
Form 13G Sutro Biopharma for: 21 April
Form 13G Sutro Biopharma for: 21 April Form 13G Sutro Biopharma for: 21 April Source: Investing.com News
Serina Therapeutics Promotes Srini Tenjarla to CTO and Updates Company Bylaws
Serina Therapeutics Promotes Srini Tenjarla to CTO and Updates Company Bylaws Serina Therapeutics Promotes Srini Tenjarla to CTO and Updates Company Bylaws Source: Investing.com News
Reborn Coffee Amends Repayment Terms with Arena Investors Under New Agreement
Reborn Coffee Amends Repayment Terms with Arena Investors Under New Agreement Reborn Coffee Amends Repayment Terms with Arena Investors Under New Agreement Source: Investing.com News
Hancock Whitney Q1 2026 Slides: Bond Restructure Drives Mixed Results
Hancock Whitney Q1 2026 Slides: Bond Restructure Drives Mixed Results Hancock Whitney Q1 2026 Slides: Bond Restructure Drives Mixed Results Source: Investing.com News
Form 13D/A FB Financial Corporation for: 21 April
Form 13D/A FB Financial Corporation for: 21 April Form 13D/A FB Financial Corporation for: 21 April Source: Investing.com News
Zymeworks: Phase 1 Trial Results for Ovarian Cancer Drug
Zymeworks: Phase 1 Trial Results for Ovarian Cancer Drug Zymeworks: Phase 1 Trial Results for Ovarian Cancer Drug Source: Investing.com News
Revolution Medicines Unveils New RAS Cancer Inhibitor Class
Revolution Medicines Unveils New RAS Cancer Inhibitor Class Revolution Medicines Unveils New RAS Cancer Inhibitor Class Source: Investing.com News
Bridgebio Oncology Presents Preclinical Data on Bbo-10203
Bridgebio Oncology Presents Preclinical Data on Bbo-10203 Bridgebio Oncology Presents Preclinical Data on Bbo-10203 Source: Investing.com News